Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial
Tags
Multiple SkleroseMS Behandlung
Jahr
2021
Autoren
Coles AJ, Arnold DL, Bass AD, Boster AL, Compston DAS, Fernández Ó, Havrdová EK, Nakamura K, Traboulsee A, Ziemssen T, Jacobs A, Margolin DH, Huang X, Daizadeh N, Chirieac MC, Selmaj KW.
Verlag
Ther Adv Neurol Disord. 2021 Apr 23;14:1756286420982134.